The Multidrug Resistance Protein 6 (MRP6), also known as ABCC6, belongs to the ATP-binding cassette (ABC) transporter superfamily and is predominantly expressed in various tissues, including the liver and kidneys. MRP6 plays a crucial role in cellular detoxification processes by actively transporting a wide range of endogenous and exogenous substrates, including drugs, toxins, and metabolites, across cellular membranes. Additionally, MRP6 is implicated in the transport of glutathione conjugates and other organic anions, thereby contributing to the cellular defense against oxidative stress and maintaining intracellular homeostasis. Furthermore, MRP6 has been associated with the transport of various molecules involved in physiological processes such as bile salt secretion, lipid metabolism, and uric acid excretion, underscoring its significance in overall organismal health.
The activation of MRP6 involves complex regulatory mechanisms that govern its transport activity and substrate specificity. One key mechanism of MRP6 activation involves post-translational modifications, including phosphorylation and glycosylation, which regulate its subcellular localization, trafficking, and transport function. Phosphorylation of specific residues within the MRP6 protein has been shown to modulate its ATPase activity and substrate recognition, thereby influencing its transport kinetics. Additionally, the interaction of MRP6 with regulatory proteins and accessory factors, such as heat shock proteins and cytoskeletal components, may further regulate its activity and contribute to its functional activation. Moreover, the transcriptional regulation of MRP6 expression by nuclear receptors and transcription factors, as well as epigenetic modifications of its gene promoter region, can influence its cellular abundance and activity levels, ultimately impacting its contribution to cellular detoxification and homeostasis. Overall, elucidating the mechanisms underlying MRP6 activation provides valuable insights into its physiological functions and offers targets for modulating its activity in various pathological conditions associated with drug resistance and metabolic disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Inhibits organic anion transporters and can influence ABC transporter function. | ||||||
MK-571 | 115103-85-0 | sc-201340 sc-201340A | 5 mg 25 mg | $109.00 $421.00 | 8 | |
MRP1 inhibitor which may indirectly affect MRP6 function. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Nonsteroidal anti-inflammatory drug (NSAID) that might influence ABC transporter activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Isoflavonoid from soy products that may modulate ABC transporter function. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
NSAID that may have an effect on certain ABC transporters. | ||||||
Fumitremorgin C | 118974-02-0 | sc-202162 | 250 µg | $408.00 | 5 | |
Known to inhibit ABCG2; its interactions might influence other ABC transporters like MRP6. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Estrogen receptor modulator which can influence ABC transporter function. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $137.00 $414.00 | 1 | |
Alkaloid that affects multiple transporters and might have an indirect effect on MRP6. | ||||||
PSC 833 | 121584-18-7 | sc-361298 sc-361298A sc-361298B sc-361298C sc-361298D | 1 mg 10 mg 50 mg 100 mg 1 g | $217.00 $738.00 $2572.00 $4338.00 $27422.00 | 12 | |
Modulates P-glycoprotein, another ABC transporter, and may influence MRP6 indirectly. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Antiarrhythmic agent that can modulate the activity of ABC transporters. | ||||||